Greenleaf Trust boosted its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 8.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,909 shares of the semiconductor company’s stock after acquiring an additional 566 shares during the period. Greenleaf Trust’s holdings in Synopsys were worth $3,353,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in SNPS. Czech National Bank lifted its stake in Synopsys by 7.3% in the third quarter. Czech National Bank now owns 31,211 shares of the semiconductor company’s stock valued at $15,805,000 after buying an additional 2,124 shares during the period. HBW Advisory Services LLC acquired a new position in Synopsys in the third quarter valued at about $265,000. GAMMA Investing LLC lifted its stake in Synopsys by 10.6% in the third quarter. GAMMA Investing LLC now owns 1,761 shares of the semiconductor company’s stock valued at $892,000 after buying an additional 169 shares during the period. Diversified Trust Co lifted its stake in Synopsys by 5.8% in the third quarter. Diversified Trust Co now owns 2,997 shares of the semiconductor company’s stock valued at $1,518,000 after buying an additional 163 shares during the period. Finally, Green Alpha Advisors LLC lifted its stake in Synopsys by 1.7% in the third quarter. Green Alpha Advisors LLC now owns 1,294 shares of the semiconductor company’s stock valued at $655,000 after buying an additional 22 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Performance
NASDAQ:SNPS opened at $525.48 on Monday. The company has a market cap of $81.23 billion, a PE ratio of 36.19, a PEG ratio of 3.44 and a beta of 1.12. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38. The stock has a 50-day simple moving average of $516.26 and a 200 day simple moving average of $520.30.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on SNPS
Insider Buying and Selling
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the transaction, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.66% of the stock is owned by corporate insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- What is the Nikkei 225 index?
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- What is diluted earnings per share (Diluted EPS)?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.